CytomX Therapeutics, Inc. (CTMX)
3.29
+0.01
(+0.30%)
USD |
NASDAQ |
Aug 24, 16:00
3.295
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Market Cap : 716.89M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 716.89M |
| August 21, 2026 | 714.71M |
| August 20, 2026 | 716.89M |
| August 19, 2026 | 777.90M |
| August 18, 2026 | 738.68M |
| August 17, 2026 | 751.75M |
| August 14, 2026 | 732.14M |
| August 13, 2026 | 729.96M |
| August 12, 2026 | 760.47M |
| August 11, 2026 | 751.75M |
| August 10, 2026 | 749.57M |
| August 07, 2026 | 753.93M |
| August 06, 2026 | 734.32M |
| August 05, 2026 | 729.96M |
| August 04, 2026 | 723.43M |
| August 03, 2026 | 690.09M |
| July 31, 2026 | 674.85M |
| July 30, 2026 | 714.04M |
| July 29, 2026 | 690.09M |
| July 28, 2026 | 700.97M |
| July 27, 2026 | 707.51M |
| July 24, 2026 | 705.33M |
| July 23, 2026 | 724.92M |
| July 22, 2026 | 724.92M |
| July 21, 2026 | 744.51M |
| Date | Value |
|---|---|
| July 20, 2026 | 766.28M |
| July 17, 2026 | 788.05M |
| July 16, 2026 | 797.85M |
| July 15, 2026 | 801.11M |
| July 14, 2026 | 796.76M |
| July 13, 2026 | 805.47M |
| July 10, 2026 | 818.53M |
| July 09, 2026 | 860.98M |
| July 08, 2026 | 833.77M |
| July 07, 2026 | 835.94M |
| July 06, 2026 | 829.41M |
| July 02, 2026 | 831.59M |
| July 01, 2026 | 783.70M |
| June 30, 2026 | 816.35M |
| June 29, 2026 | 814.18M |
| June 26, 2026 | 740.16M |
| June 25, 2026 | 711.86M |
| June 24, 2026 | 722.74M |
| June 23, 2026 | 685.74M |
| June 22, 2026 | 661.79M |
| June 18, 2026 | 642.20M |
| June 17, 2026 | 644.37M |
| June 16, 2026 | 637.84M |
| June 15, 2026 | 661.79M |
| June 12, 2026 | 655.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 85.67B |
| Ocugen, Inc. | 461.10M |
| iBio, Inc. | 49.05M |
| Cardiff Oncology, Inc. | 68.36M |
| Capricor Therapeutics, Inc. | 395.14M |
Market Cap Related Metrics
| PS Ratio | 32.87 |
| Price to Book Value | 2.373 |
| Price | 3.29 |
| Earnings Yield | -13.89% |